Lupin informs about press release

26 May 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, the Company has entered into a license and supply agreement with SteinCares, a leading specialty healthcare company in Latin America, for commercialization of Lupin’s biosimilar ranibizumab across Latin America excluding Mexico and Argentina.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2152.60 -12.45 (-0.58%)
23-Jan-2026 10:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1630.00
Dr. Reddys Lab 1244.60
Cipla 1380.55
Zydus Lifesciences 889.90
Lupin 2152.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×